Medivolve Inc. Stock NEO Exchange
Equities
MEDV
CA58503M4083
Advanced Medical Equipment & Technology
Sales 2022 | 37.18 51.07 | Sales 2023 | 0.69 0.94 | Capitalization | 390K 536K |
---|---|---|---|---|---|
Net income 2022 | -18M -24.73M | Net income 2023 | -16M -21.98M | EV / Sales 2022 | 22,108 x |
Net cash position 2022 | 2.64M 3.63M | Net Debt 2023 | 665K 913K | EV / Sales 2023 | 1,537,011 x |
P/E ratio 2022 |
-0.19
x | P/E ratio 2023 |
-0.02
x | Employees | 25 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.14% |
Managers | Title | Age | Since |
---|---|---|---|
David Preiner
CEO | Chief Executive Officer | - | 21-04-29 |
Evan Veryard
IRC | Investor Relations Contact | - | - |
1st Jan change | Capi. | |
---|---|---|
-4.06% | 29.86B | |
+36.88% | 9.06B | |
+38.02% | 4.55B | |
-34.39% | 2.49B | |
-14.11% | 1.52B | |
-25.83% | 1.28B | |
-38.46% | 1.05B | |
+4.27% | 932M | |
-41.98% | 809M |